Light Horse Therapeutics

Light Horse Therapeutics Inc. is a leader in precision genomic editing for small molecule drug discovery, pioneering approaches that target the root causes of debilitating and life-threatening diseases. Its advanced platform identifies cryptic chemically addressable functional domains within targets, which play critical roles in disease biology. The high-throughput discovery platform systematically interrogates complex signaling pathways to uncover unique vulnerabilities. Light Horse Therapeutics studies these targets in their native cellular environments to best ensure that discoveries in the lab translate to the clinic.